Legis Daily

John S. McCain Opioid Addiction Prevention Act

USA116th CongressHR-1614| House 
| Updated: 4/12/2019
John Katko

John Katko

Republican Representative

New York

Cosponsors (7)
Guy Reschenthaler (Republican)Thomas R. Suozzi (Democratic)Carol D. Miller (Republican)Dean Phillips (Democratic)Chris Collins (Republican)Susan W. Brooks (Republican)Susie Lee (Democratic)

Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
John S. McCain Opioid Addiction Prevention Act This bill establishes a new registration requirement for practitioners who are licensed to prescribe controlled substances in schedule II, III, or IV. Specifically, a practitioner must agree to limit the supply of opioids prescribed for the initial treatment of acute pain, as a condition of obtaining or renewing a registration through the Drug Enforcement Administration. An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 7, 2019

Latest Companion Bill Action

S 116-724
Introduced in Senate
Mar 7, 2019
Introduced in House
Mar 7, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 8, 2019
Referred to the Subcommittee on Health.
Apr 12, 2019
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
  • March 7, 2019

    Latest Companion Bill Action

    S 116-724
    Introduced in Senate


  • March 7, 2019
    Introduced in House


  • March 7, 2019
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • March 8, 2019
    Referred to the Subcommittee on Health.


  • April 12, 2019
    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Crime and Law Enforcement

Related Bills

  • S 116-724: John S. McCain Opioid Addiction Prevention Act
Drug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesHealth personnelLicensing and registrationsPrescription drugs

John S. McCain Opioid Addiction Prevention Act

USA116th CongressHR-1614| House 
| Updated: 4/12/2019
John S. McCain Opioid Addiction Prevention Act This bill establishes a new registration requirement for practitioners who are licensed to prescribe controlled substances in schedule II, III, or IV. Specifically, a practitioner must agree to limit the supply of opioids prescribed for the initial treatment of acute pain, as a condition of obtaining or renewing a registration through the Drug Enforcement Administration. An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 7, 2019

Latest Companion Bill Action

S 116-724
Introduced in Senate
Mar 7, 2019
Introduced in House
Mar 7, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 8, 2019
Referred to the Subcommittee on Health.
Apr 12, 2019
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
  • March 7, 2019

    Latest Companion Bill Action

    S 116-724
    Introduced in Senate


  • March 7, 2019
    Introduced in House


  • March 7, 2019
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • March 8, 2019
    Referred to the Subcommittee on Health.


  • April 12, 2019
    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
John Katko

John Katko

Republican Representative

New York

Cosponsors (7)
Guy Reschenthaler (Republican)Thomas R. Suozzi (Democratic)Carol D. Miller (Republican)Dean Phillips (Democratic)Chris Collins (Republican)Susan W. Brooks (Republican)Susie Lee (Democratic)

Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

Crime and Law Enforcement

Related Bills

  • S 116-724: John S. McCain Opioid Addiction Prevention Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Drug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesHealth personnelLicensing and registrationsPrescription drugs